Related Experiment Video
Updated: Aug 8, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Hidden tricks in MATH: Hypermorphic mutations in SPOP tumor suppressor explained by cryo-EM
Jacob J Orme1, Georges Mer2, Haojie Huang2
1Division of Medical Oncology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.
Abstract:
Loss-of-function mutations in SPOP E3 ubiquitin ligase drive multiple cancers. However, carcinogenic gain-of-function SPOP mutations have been a major puzzle. In this issue of Molecular Cell, Cuneo et al.1 show that several mutations map to SPOP oligomerization interfaces. Additional questions remain about SPOP mutations in malignancy.
Insights
Gain-of-function mutations in the SPOP gene, a ubiquitin ligase, can drive cancer. This study reveals these cancer-driving mutations cluster at SPOP
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- SPOP (Speckle-type POZ protein) functions as an E3 ubiquitin ligase substrate adaptor.
- Loss-of-function SPOP mutations are established drivers in various cancers.
- The oncogenic role of gain-of-function SPOP mutations remains poorly understood.
Purpose of the Study:
- To investigate the structural and functional consequences of cancer-associated SPOP mutations.
- To elucidate the mechanisms by which gain-of-function SPOP mutations contribute to malignancy.
Main Methods:
- Structural analysis of SPOP protein.
- Biochemical assays to assess SPOP ligase activity and substrate binding.
- Bioinformatic analysis of mutation data.
Main Results:
- Several oncogenic SPOP mutations were identified to map directly onto SPOP oligomerization interfaces.
- These mutations likely disrupt SPOP's normal function and/or promote novel oncogenic activities.
- The findings provide a structural basis for understanding SPOP-driven tumorigenesis.
Conclusions:
- Gain-of-function mutations in SPOP can promote cancer by altering its oligomerization.
- Further research is needed to fully understand the implications of SPOP mutations in cancer.
- Targeting SPOP pathways may offer new therapeutic strategies for SPOP-mutated cancers.
More Related Videos
09:35Analysis of Somatic Hypermutation in the JH4 intron of Germinal Center B cells from Mouse Peyer's Patches
Published on: April 20, 2021
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation